Wissenschaftliche HPI-Publikationen zu COVID-19 (SARS-CoV-2)

Pfefferle S, Kobbe R, Guenther T, Noerz D, Santer R, Oh J, Kluge S, Oestereich L, Peldschus K, Indenbirken D, Huang J, Grundhoff A, Aepfelbacher M, Knobloch J, Fischer N, Luetgehetmann M. Infection Control and Virological Assessment of the First Cluster of COVID-19 in Northern Germany (April 10, 2020). Available at SSRN: https://ssrn.com/abstract=3572733 or http://dx.doi.org/10.2139/ssrn.3572733 PREPRINT

Schroeder M, Tuku B, Jarczak D, Nierhaus A, Bai T, Jacobsen H, Zickler M, Mueller Z, Stanelle-Bertram S, Meinhardt A, Aberle J, Kluge S, Gabriel G (2020). The majority of male patients with COVID-19 present low testosterone levels on admission to Intensive Care in Hamburg, Germany: a retrospective cohort study. medRxiv 2020.05.07.20073817 (May 11, 2020). Available at medRxiv: https://doi.org/10.1101/2020.05.07.20073817 PREPRINT *

* Study based on insights from: Chen Y, Bai T, Beck S, Stanelle-Bertram S, Chen T, Dong J, Yang J, Wang L, Wang D, Shu Y, Gabriel G (2020). Low testosterone and high cytokine levels correlate with lethal H7N9 infections in men: a retrospective cohort study from 98 H7N9 patients. medRxiv 2020.05.07.20093914. https://doi.org/10.1101/2020.05.07.20093914 PREPRINT